Patents by Inventor Shingo Matsushima

Shingo Matsushima has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-ALCOHOLIC BEER-TASTE BEVERAGE
    Publication number: 20240156131
    Abstract: An object of the invention is to provide a non-alcohol beer-taste beverage excellent in robust feeling of drinking and also excellent in foam quality. The means for solving the problems is a non-alcohol beer-taste beverage containing a wort fermented liquid, having a malt use ratio of 50% or more, a real extract concentration of 6 w/v % or more, and a ratio of bitterness value (BU) to real extract concentration (w/v %) (bitterness value/real extract) of 2.0 to 3.8.
    Type: Application
    Filed: March 22, 2022
    Publication date: May 16, 2024
    Applicant: Asahi Group Holdings, Ltd.
    Inventors: Wataru NAKAYAMA, Takemasa MATSUSHIMA, Shingo NAKAKAWAJI
  • LOW ALCOHOL BEER-TASTE BEVERAGE
    Publication number: 20240138443
    Abstract: An object of the invention is to provide a low-alcohol beer-taste beverage having an excellent beer-like flavor at the top, and an enhanced complex taste derived from brewing. The means for solving the problem is a non-alcoholic beer-taste beverage containing an aroma composition containing 0.0475 ppb or more of myrcene, 0.000475 ppb or more of ?-ionone, 5.8125 ppb or more of linalool, 0.7025 ppb or more of citronellol, 0.115 ppb or more of geraniol, and 0.09 ppb or more of ?-eudesmol.
    Type: Application
    Filed: January 21, 2022
    Publication date: May 2, 2024
    Applicant: Asahi Group Holdings, Ltd.
    Inventors: Wataru NAKAYAMA, Takemasa MATSUSHIMA, Shingo NAKAKAWAJI
  • Method of treating ischemia/reperfusion injury
    Patent number: 9737532
    Abstract: An agent for treating ischemia/reperfusion injury, including a therapeutically effective amount of a p53 agonist compound including a cis-imidazoline structure.
    Type: Grant
    Filed: January 27, 2012
    Date of Patent: August 22, 2017
    Assignee: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
    Inventors: Yoshikazu Higami, Naoyuki Okita, Shingo Matsushima
  • Method of Treating Ischemia/Reperfusion Injury
    Publication number: 20130317042
    Abstract: An agent for treating ischemia/reperfusion injury, including a therapeutically effective amount of a p53 agonist compound including a cis-imidazoline structure.
    Type: Application
    Filed: January 27, 2012
    Publication date: November 28, 2013
    Applicant: TOKYO UNIVERSITY OF SCIENCE FOUNDATION
    Inventors: Yoshikazu Higami, Naoyuki Okita, Shingo Matsushima